Decoy Therapeutics Inc.
Pharmaceutical company · Houston, Texas, United States · Nasdaq: DCOY
Decoy Therapeutics Inc. is a pharmaceutical company headquartered in Houston, Texas, United States. Its earliest recorded incorporation is in 2014. Its shares trade on Nasdaq under the ticker DCOY. It has reported private securities offerings to the US SEC, most recently $6 million sold in a notice filed in 2023.
Decoy Therapeutics at a glance
What does Decoy Therapeutics do?
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $6 million sold (2023).
Frequently asked questions about Decoy Therapeutics
Where is Decoy Therapeutics headquartered?
Decoy Therapeutics Inc. is headquartered in Houston, Texas, United States.
What does Decoy Therapeutics do?
Decoy Therapeutics Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Decoy Therapeutics a public company?
Yes. Decoy Therapeutics Inc. trades on Nasdaq under the ticker DCOY.
When was Decoy Therapeutics founded?
The earliest incorporation on record for Decoy Therapeutics Inc. is in 2014, according to public company registers.
Similar companies
- Marker Therapeutics, Inc.Houston, Texas, United States
- 7 Hills Pharma Inc.Houston, Texas, United States
- CNS Pharmaceuticals, Inc.Houston, Texas, United States
- Coya Therapeutics, Inc.Houston, Texas, United States
- Aravive, Inc.Houston, Texas, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.